Multi Vaccines Development Program Ngo Information
Multi Vaccines Development Program Non Governmental Organization is located in DelhiDELHI .
Registration Details
Registered With
Registrar of Societies
Type of NGO
Registered Societies (Non-Government)
Registration No
S/ND/0020/2010
Copy of Registration Certificate
Available
Copy of Pan Card
Available
Act name
Indian Societies Registration Act, 1860
City of Registration
Delhi
State of Registration
DELHI
Date of Registration
14-07-2010
Foreign Contribution Regulation Act [FRCA] Registered? NO
Multi Vaccines Development Program NGO Organization Members
Name
Designation
Pan
Aadhaar
Virander Singh Chauhan
President
Available
Available
Chaitanya Eknath Chitnis
Secretary
Available
Available
Dinakar Masanu Salunke
Member
Available
Available
Multi Vaccines Development Program Source Funds
Department Name
Source
Finacial Year
Amount Sanctioned
Purpose
Not Specified
Any Other
2015-2016
Not Specified
Multi Vaccines Development Program was established in 2010 for advancing vaccine research including conduct of clinical trials. Department of Biotechnology (DBT), International Centre for Genetic Engineering and Biotechnology (ICGEB) and Malaria Vaccine Initiative (MVI), PATH, came together to support the establishment of MVDP. ICGEB and DBT provided funding (INR 12,03,57,879/-) to establish MVDP as an independent society.
Not Specified
Any Other
2016-2017
Not Specified
MVDP core sustenance was covered by the grant received from ICGEB. MVDP raised additional funds for malaria vaccine development projects. It received FCRA prior permission in 2012 to receive USD 8,11,023 from PATH-MVI for advancement of P. vivax malaria vaccine development. In addition, DBT provided funds for development of malaria vaccines using influenza VLP platform (INR 6,50,000) and for development of a recombinant combination blood stage vaccine for P. falciparum malaria (INR 2,90,00,000).
Not Specified
Any Other
2017-2018
Not Specified
The core expenditures of MVDP were covered by initial grant received from ICGEB and interest of INR 2,99,22,012 that was earned on the core grant received. The interest earned supported functioning of MVDP in 2017- 2018. MVDP successfully completed the preclinical toxicology studies and initiated Phase I clinical trial with PvDBPII, a novel recombinant vaccine candidate for Plasmodium vivax. MVDP also transferred the technology for cGMP production of the P. falciparum malaria vaccines to a CMO.
Not Specified
Any Other
2018-2019
Not Specified
MVDP continues to utilize the remaining interest money earned on the core grant for functioning of the organization and support ongoing malaria vaccine. During this period MVDP successfully completed the Phase I clinical trial with PvDBPII, a novel recombinant P. vivax vaccine candidate. Besides successfully completing preclinical toxicology studies, MVDP initiated a Phase I clinical trial with another novel recombinant P. falciparum vaccine candidate with funding support from DBT and BIRAC.
Contact details
Address
International Centre For Genetic Engineering and Biotechnology (ICGEB Campus) Aruna Asaf Ali Marg, New Delhi -110067
Multi Vaccines Development Program Key Issues and
Operational Areas, Major Activiities & Achivements
Operational Districts: New Delhi
Operational States: DELHI
AchieveMents: Multi Vaccines Development Program is the first and one of its kind translational development program for vaccine development based in India. In last 8 years, MVDP and ICGEB in collaboration has resulted in transition of three malaria vaccine candidates (2 for P. falciparum and 1 for P. vivax) from ICGEB lab to Phase I first-in-man clinical trials. Two Phase I clinical trials have already been completed and a third with another novel P. falciparum malaria vaccine will be initiated soon.
